INHALE DELIVERS

Welcome to the Brand page for “INHALE DELIVERS”, which is offered here for Custom adaptation, alteration, and reformulation of pharmaceuticals produced by others to render them suitable for administration in aerosol form as fine, dry particles;pharmaceutical preparations for treatment of diseases and medical conditions of the peripheral nerve, of the adrenergic and cholinergic receptors; of the skeletal and smooth muscle systems, cardiovascular systems, endocrine and hormone systems, blood circulatory and immunological systems, of the synoptic and neuroeffector junctional sites, of the reproductive, skeletal and autacoid systems, the alimentary and excretory systems, and the histamine and central nervous systems, in the nature of drugs for delivery in aerosol form as fine dry particles to the deep lung, otherwise requiring other drug delivery means for treatment;.

Its status is currently believed to be active. Its class is unavailable. “INHALE DELIVERS” is believed to be currently owned by “INHALE THERAPEUTIC SYSTEMS”.


Owner:
INHALE THERAPEUTIC SYSTEMS
Owner Details
Description:
CUSTOM ADAPTATION, ALTERATION, AND REFORMULATION OF PHARMACEUTICALS PRODUCED BY OTHERS TO RENDER THEM SUITABLE FOR ADMINISTRATION IN AEROSOL FORM AS FINE, DRY PARTICLES;PHARMACEUTICAL PREPARATIONS FOR TREATMENT OF DISEASES AND MEDICAL CONDITIONS OF THE PERIPHERAL NERVE, OF THE ADRENERGIC AND CHOLINERGIC RECEPTORS; OF THE SKELETAL AND SMOOTH MUSCLE SYSTEMS, CARDIOVASCULAR SYSTEMS, ENDOCRINE AND HORMONE SYSTEMS, BLOOD CIRCULATORY AND IMMUNOLOGICAL SYSTEMS, OF THE SYNOPTIC AND NEUROEFFECTOR JUNCTIONAL SITES, OF THE REPRODUCTIVE, SKELETAL AND AUTACOID SYSTEMS, THE ALIMENTARY AND EXCRETORY SYSTEMS, AND THE HISTAMINE AND CENTRAL NERVOUS SYSTEMS, IN THE NATURE OF DRUGS FOR DELIVERY IN AEROSOL FORM AS FINE DRY PARTICLES TO THE DEEP LUNG, OTHERWISE REQUIRING OTHER DRUG DELIVERY MEANS FOR TREATMENT;
Categories: CUSTOM ADAPTATION